Stacey L. House, Ph.D.
Affiliations: | 2005 | University of Cincinnati, Cincinnati, OH |
Area:
Molecular Biology, PharmacologyGoogle:
"Stacey House"Parents
Sign in to add mentor| Jo El J. Schultz | grad student | 2005 | University of Cincinnati | |
| (Role of fibroblast growth factor 2 in cardiac ischemia -reperfusion injury and hypertrophy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Matsiukevich D, House SL, Weinheimer C, et al. (2022) Fibroblast growth factor receptor signaling in cardiomyocytes is protective in the acute phase following ischemia-reperfusion injury. Frontiers in Cardiovascular Medicine. 9: 1011167 |
| House SL, Castro AM, Lupu TS, et al. (2016) Endothelial Fibroblast Growth Factor Receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00758.2015 |
| House SL, Wang J, Castro AM, et al. (2015) Fibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injury. Physiological Reports. 3 |
| Cilvik SN, Wang JI, Lavine KJ, et al. (2013) Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy. Plos One. 8: e82979 |
| Manning JR, Carpenter G, Porter DR, et al. (2012) Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels. Growth Factors (Chur, Switzerland). 30: 124-39 |
| House S, Weinheimer C, Kovacs A, et al. (2011) 187 EMFEndogenous Fibroblast Growth Factor 2 Protects the Heart in a Murine Model of Closed Chest Regional Ischemia-Reperfusion Injury Annals of Emergency Medicine. 58: S240 |
| House SL, House BE, Glascock B, et al. (2010) Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase. Molecular and Cellular Pharmacology. 2: 143-154 |
| House SL, Newman G, Schultz JJ. (2010) 14 EMF: Human Recombinant Low Molecular Weight Fibroblast Growth Factor 2 Protects the Heart From Reperfusion Injury Through Activation of FGF Receptors and Nitric Oxide Signaling Annals of Emergency Medicine. 56 |
| House SL, Melhorn SJ, Newman G, et al. (2007) The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2. American Journal of Physiology. Heart and Circulatory Physiology. 293: H354-65 |
| House SL, Branch K, Newman G, et al. (2005) Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade. American Journal of Physiology. Heart and Circulatory Physiology. 289: H2167-75 |